tiprankstipranks
VYNE Therapeutics sees cash runway through end of 2025
PremiumThe FlyVYNE Therapeutics sees cash runway through end of 2025
3M ago
VYNE Therapeutics reports Q2 EPS (22c) vs. ($3.09) last year
Premium
The Fly
VYNE Therapeutics reports Q2 EPS (22c) vs. ($3.09) last year
3M ago
Vyne Therapeutics Inc (VYNE) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Vyne Therapeutics Inc (VYNE) Q2 Earnings Cheat Sheet
4M ago
VYNE Therapeutics expects cash to fund operations through 2025
PremiumThe FlyVYNE Therapeutics expects cash to fund operations through 2025
7M ago
VYNE Therapeutics reports Q1 EPS (15c) vs. ($1.74) last year
Premium
The Fly
VYNE Therapeutics reports Q1 EPS (15c) vs. ($1.74) last year
7M ago
VYNE Therapeutics announces FDA clearance of IND application for VYN202
Premium
The Fly
VYNE Therapeutics announces FDA clearance of IND application for VYN202
7M ago
VYNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsVYNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
9M ago
VYNE Therapeutics announces biomarker data from Phase 1b trial of VYN201
Premium
The Fly
VYNE Therapeutics announces biomarker data from Phase 1b trial of VYN201
11M ago
VYNE Therapeutics appoints Borowski to board of directors
Premium
The Fly
VYNE Therapeutics appoints Borowski to board of directors
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100